Wolverine Trading »

Rapt Therapeutics shares owned by Wolverine Trading

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Wolverine Trading from 13F filings

Historical chart of Wolverine Trading investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Wolverine Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Wolverine Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $497k 55k 8.98

More positions owned by Wolverine Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Cl A New (MSTR)
Ishares Tr Core S&p500 Etf Call Option (IVV)
Tesla Motors (TSLA)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Vanguard Index Fds S&p 500 Etf Shs Put Option (VOO)
Super Micro Computer (SMCI)
Advanced Micro Devices (AMD)

View all positions for Wolverine Trading

Top funds holding Rapt Therapeutics

FMR
Column Group
Vanguard Group
BlackRock
T. Rowe Price Associates
Morgan Stanley
Kingdon Capital Management
Perceptive Advisors
Geode Capital Management
Redmile Group
State Street Corporation
Euclidean Capital
Affinity Asset Advisors
Dimensional Fund Advisors
Alphabet

View all funds holding Rapt Therapeutics